News

Pre-market futures had been up across the board, but have fallen off the table in recent minutes. We’re now 25 minutes before the opening bell, and we still have yet to see the Personal Consumption

Simon Property Group SPG owns a diversified portfolio of premium retail assets in some of the key markets across the United States and globally. Solid retail real estate demand is likely to drive

Exodus Movement EXOD is growing fast as a self-custodial wallet and Web3 financial services solution provider. Exodus Movement revenues climbed 51% year over year on the back of rising digital asset

A recent analysis from the U.S. Energy Information Administration (EIA), published on Dec. 3, 2025, highlights how geopolitical tensions have significantly pushed up diesel prices and thereby global

Economic growth worldwide is set to hit its lowest levels since the pandemic. However, according to TradingView, Fitch Ratings and the OECD now see the outlook as slightly stronger than expected

Zacks Investment Research has recently initiated coverage of Inspire Veterinary Partners Inc. IVP with an Underperform rating, citing persistent financial headwinds and structural challenges that

Shares of Absci Corporation ABSI jumped 13.4% on Thursday after the company initiated dosing in an early-to-mid-stage study evaluating its investigational candidate, ABS-201, for androgenetic

Shares of Capricor Therapeutics CAPR have skyrocketed 281.9% this week. The massive stock price surge was observed after the company reported positive top-line results from a late-stage study of

Hewlett Packard Enterprise HPE stock declined more than 8% in the pre-market hours despite reporting better-than-expected results for fourth-quarter fiscal 2025. The company’s non-GAAP earnings of

D-Wave Quantum’s QBTS third-quarter 2025 results show an improvement in the company’s operations. The company reported gross profit of $2.7 million, up 156% year over year. Meanwhile, GAAP gross

Nu Holdings’ NU strongest differentiator at this stage of its growth cycle is its rising revenue durability, the company’s ability to convert a massive customer base into recurring, multi-product

Friday, December 5, 2025Pre-market futures had been up across the board, but have fallen off the table in recent minutes. We’re now 25 minutes before the opening bell, and we still have yet to see

Gap Inc. GAP delivered an impressive third-quarter fiscal 2025 performance, highlighted by broad-based strength across its key brands. Company-wide comps rose 5%, the highest in more than four

The Bank of New York Mellon Corporation’s BK shares touched a new 52-week high of $114.43 in Thursday’s trading session. Over the past six months, BK stock has gained 26.2%, outperforming the indust

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 5: 

Credo Technology Group Holding Ltd CRDO: This connectivity solutions provider has a

AST SpaceMobile, Inc. ASTS shares were up 18.3% yesterday, driven by the euphoria related to its upcoming BlueBird satellite launch on Dec. 15. The uptrend was also buoyed by OpenAI CEO Sam Altman’s

The market’s rally has been fueled by AI for quite some time now, with the “Magnificent Seven” significantly outperforming the S&P 500 and accounting for much of the gains. This outperformance is

KBR, Inc. KBR has expanded its U.K. presence after securing a U.S. Navy contract to provide Foreign Military Sales support for the Naval Air Systems Command’s (NAVAIR) F/A-18 and EA-18G Program

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and has risen 85.43% from its 52-week low price of $66.66/share.

But

Amicus Therapeutics FOLD has been making meaningful progress with its lead product, Galafold (migalastat), which has been driving the majority of the company’s revenues. The drug has remained a key

Denali Therapeutics Inc. DNLI has announced a funding agreement with Royalty Pharma plc RPRX for $275 million. The stock gained 5.84% following the announcement.

The deal centers on future net sales

Shares of Atlassian (TEAM) have gained 0.3% over the past four weeks to close the last trading session at $156.54, but there could still be a solid upside left in the stock if short-term price

Benitec Biopharma Limited (BNTC) closed the last trading session at $13.18, gaining 9.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Profound Medical (PROF) closed the last trading session at $6.75, gaining 15.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by